tiprankstipranks
Trending News
More News >
Rein Therapeutics (RNTX)
NASDAQ:RNTX
US Market

Rein Therapeutics (RNTX) Income Statement

Compare
1,195 Followers

Rein Therapeutics Income Statement

Last quarter (Q4 2024), Rein Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Rein Therapeutics's net income was $-40.98M. See Rein Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 65.11K$ 16.28K$ 27.65K$ 26.61K$ 20.50K
Depreciation and Amortization
$ 63.00K$ 119.00$ 169.00$ 121.00$ 163.00
EBITDA
$ -28.05M$ -15.23K$ -27.48K$ -26.48K$ -20.33K
Operating Income
$ -65.11M$ -16.28K$ -27.65K$ -26.61K$ -20.50K
Other Income/Expenses
$ 800.00K$ 544.00$ 318.00$ 441.00$ -661.00
Pretax Income
$ -64.31M$ -15.73K$ -27.33K$ -26.16K$ -21.16K
Net Income
$ -62.88M$ -15.73K$ -27.33K$ -26.16K$ -21.16K
Per Share Metrics
Basic EPS
$ -3.51$ -3.42$ -6.02$ -5.89$ -12.14
Diluted EPS
$ -3.51$ -3.42$ -6.02$ -5.89$ -12.14
Weighted Average Shares Outstanding
17.94K 4.60K 4.54K 4.44K 1.74K
Weighted Average Shares Outstanding (Diluted)
17.94K----
Currency in USD

Rein Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis